San Diego, California – August 30, 2022 – Eyes On Eyecare® today announced that Michael S. Cooper, OD, more commonly known as “Coop,” has joined its growing team of eyecare specialists to further the creative organization’s position as the trusted resource the next generation of optometrists and ophthalmologists turns to for education, content, and business trends.
“We are thrilled to have Coop on the team,” said Matt Geller, OD, co-founder and CEO of CovalentCreative, the parent company of Eyes On Eyecare. “For the last decade, he’s been at the forefront of innovation at companies like Johnson & Johnson Vision Care, Allergan, Alcon, Zeiss, Bausch Health, Sight Sciences and recently with Kala Pharmaceuticals. Combined with his experience as a practicing OD, we’re excited about breaking new ground in medical education and delivering content that will advance careers and enable today’s eyecare professionals to practice at the top of their licenses.”
Dr. Cooper’s new role will ensure that today’s eyecare professionals can acquire breakthrough medical insight on topics including, ocular surface disease, age-related macular degeneration (AMD), glaucoma, myopia/presbyopia, contact lenses, refractive surgery, and practice management, to name a few.
“I’m excited to use my clinical knowledge and bench science skills to enhance patient care in a new way,” said Dr. Cooper. “It’s an honor and privilege to serve in this inaugural role with a laser-focused team, and I’m looking forward to flexing my creative muscles to provide innovative educational content for optometrists and ophthalmologists.”
Dr. Cooper is a respected optometrist and past Director of Professional Strategies at Kala Pharmaceuticals in Arlington, MA. Additionally, he co-founded Intrepid Eye Society in 2015 which comprises a diverse group of emerging thought leaders with a goal to promote excellence and growth within the ophthalmic space. He specializes in anterior segment disease, where he treats and lectures domestically and internationally on a variety of conditions, including dry eye/ external lid diseases, allergy, uveitis, sports-related eye injuries in children, AMD pedigree relationships, and more. Dr Cooper has served on numerous scientific advisory boards, provided spokesperson support for various OTC drug launches, and has consulted for multiple industry partners focusing on market strategy and development. His work has been published in both peer-reviewed and trade journals such as: Review of Optometry, Clinical Ophthalmology, Modern Optometry, Cataract and Refractive Surgery Today, Optometry/Ophthalmology Times, The Ophthalmologist, Chain Drug Review, Dulaney Foundation ophthalmic supplements, Primary Care Optometry News, and Optometric/Ophthalmology Management.
Additionally, Dr. Cooper has been actively involved in global clinical studies for novel, anti-infective therapeutics, evaluating the efficacy of meibomian gland treatment modalities, ocular surface diagnostic validation, retrospective glaucoma real-world chart review analyses, and AMD genetic research at the University of Michigan, Ann Arbor. In 2020, he was awarded a federal grant to evaluate diabetes care efficiently across a multispecialty environment within a community health center setting.
###
About Eyes On Eyecare
Eyes On Eyecare delivers leading-edge clinical and career education to the next generation of optometrists and ophthalmologists through premier content and virtual events, including Eyes On 2023, Eyes On Dry Eye, Eyes On Glaucoma, and more. Eyes On Eyecare is operated by CovalentCreative, which has launched notable brands like CovalentCareers, OptometryStudents.com, and NewGradOptometry.com. Based out of San Diego, CA, CovalentCreative boasts an elite team of nearly 40 individuals with a combined 70+ years of clinical, media, content, and talent acquisition experience in the optometry and ophthalmology space.
For more information, contact Brett Kestenbaum at 858-780-4455 or via email at brett@covalentcreative.com.
